Health claims

Scientific Gap analysis of the data in accordance with Regulatory admissibility criteria

  • EFSA opinions and guidance on the same applications/ingredients.
  • Clinical studies on the applications/ingredients
  • Characterization data on the applications/ingredients

Experts Recommendations

  • Strengths and weaknesses of the substantiation
  • Suggestion of alternative claims to apply, in line with your expectations, general EFSA requirements and available scientific data.
  • Complementary elements to provide including additional clinical studies.

File constitution & submission

  • Preparation of the health claim file.
  • National then EFSA authority submission

Authorities follow up & exchange (Member states, EFSA & European Commission

You are interested
Contact Us

Dedicated Physiology & Biochemistry PhD experts

The best expertise on the market
Example of Health claims success
New Health Claim for Nutriose ® 06 from Roquette Freres - 12/11/2014
Nutraveris has get a positive opinion for Nutriose® 06, a resistant dextrin made from wheat or maize starch, developed and commercialized by the French company Roquette Freres, one of the five world leaders in the starch manufacturing industry. The application, related to the reduction of post-prandial glycaemic response, provided six proprietary and unpublished clinical trials in accordance with EFSA requirements.
Positive opinion for Sylvan Bio’s Health Claim on red yeast rice - 12/02/2013
Nutraveris succeeded in getting a positive opinion from EFSA for the French company Sylvan Bio, on a claim promoting the cholesterol-managing effects of their red yeast rice, under article 13.5 of the EU Health Claim regulation. EFSA’s opinion recognizes that monacolin K in Sylvan Bio red yeast rice is sufficiently characterized. The maintenance of normal blood LDL-cholesterol concentrations has been also acknowledged by EFSA as a beneficial physiological effect. However, the main factor that made this achievement possible is the proven efficacy of Sylvan Bio’s red yeast rice to lower LDL-cholesterol levels in blood, as clearly highlighted by two proprietary clinical trials. These studies, conducted in a population accepted by EFSA (i.e. non-treated hypercholesterolemic subjects), have shown a significant reduction in LDL-cholesterol levels after at least 12 weeks of consumption of Sylvan Bio’s Red yeast rice.




Nutraveris Experts
- See more Services :